Abstract Schistosomiasis is a major tropical disease caused by trematode helminths in which the host mounts a pathogenic immune response against tissue-trapped parasite eggs. The immunopathology consists of egg antigen-specific CD4 T cell-mediated granulomatous inflammation that varies greatly in magnitude in humans and among mouse strains in an experimental model. New evidence, covered in this review, intimately ties the development of severe pathology to IL-17-producing CD4 T helper (Th17) cells, a finding that adds a new dimension to the traditional CD4 Th1 vs. Th2 cell paradigm. Most examined mouse strains, in fact, develop severe immunopathology with substantial Th17 as well as Th1 and Th2 cell responses; a solely Th2-polarized response is an exception that is only observed in low-pathology strains such as the C57BL/6. The ability to mount pathogenic Th17 cell responses is genetically determined and depends on the production of IL-23 and IL-1β by antigen presenting cells following recognition of egg antigens; analyses of several F2 progenies of (high×low)-pathology strain crosses demonstrated that quantitative trait loci governing IL-17 levels and disease severity vary substantially from cross to cross. Low pathology is dominant, which may explain the low incidence of severe disease in humans; however, coinfection with intestinal nematodes can also dampen pathogenic Th17 cell responses by promoting regulatory mechanisms such as those afforded by alternatively activated macrophages and T regulatory cells. A better understanding of the pathways conducive to severe forms of schistosomiasis and their regulation should lead to interventions similar to those presently used to manage other immune-mediated diseases.
Introduction to schistosomiasis
Schistosomiasis is an ancient parasitic disease caused by trematode helminths that continues to afflict over 200 million people throughout tropical regions of the world. It is contracted by humans (and other vertebrates) when wading in bodies of fresh water contaminated with free-swimming cercariae, the larval and infective form of the schistosomes released from aquatic vector snails. Cercariae penetrate the skin, and over a period of a few weeks mature into adult worms that home to a specific anatomic site within the host's venous vasculature, where males and females mate and lay eggs. The eggs exit the vascular compartment to access an emunctory organ that will set them free in search of the appropriate vector snails for the purpose of propagating the life cycle. However, many eggs are trapped locally in the process of exiting or embolize in regional organs where they precipitate a fierce immune response, which, if undisturbed, sets off lifelong immunopathology and disease that can result in death.
Of the many existing schistosome species in nature, Schistosoma mansoni, Schistosoma japonicum and Schistosoma hematobium are the main human pathogens. In the first two cases, the adult worms colonize the mesenteric vascular plexus and consequently their eggs mostly affect the liver and intestine, whereas in the latter the worms home to the perivesicular veins and produce pathology predominantly in the bladder. In this review, we focus mainly on S. mansoni, which is the most extensively studied species and also serves as an excellent and remarkably faithful model of experimental schistosomiasis in the mouse.
Human schistosomiasis mansoni occurs in two forms: the now less common acute form contracted mostly by visitors to endemic areas, and the chronic form affecting vast segments of the local populations in areas of Africa and northeastern South America. It has been known for a long time that most chronic patients develop relatively mild "intestinal" schistosomiasis, whereas only 5-10 % suffer the severe "hepatosplenic" form of the disease, in which there is progressive liver fibrosis, portal hypertension, splenomegaly, ascites, gastrointestinal hemorrhage, and death [1] . While schistosomiasis is currently susceptible to curative treatment with drugs such as praziquantel, swift re-infection unfortunately remains a serious drawback to eliminating the disease. No vaccine is available to this date despite vast efforts, the description of which is outside the scope of this article. Greater general details about schistosomiasis can be found in a number of informative review articles [1] [2] [3] [4] .
In all cases of schistosomiasis, the key pathology is a granulomatous inflammatory reaction against tissuetrapped parasite eggs, and it is the nature of the host immune response, rather than the parasite itself, that shapes the magnitude of immunopathology in each case. Much about the mechanisms governing the development and regulation of the pathogenic immune response in schistosomiasis has been learned from observations in the mouse.
The murine model
Murine susceptibility to patent infection with the hepatotropic species S. mansoni and S. japonicum has allowed for extensive investigation of this parasitic disease in a host in which a well-understood immune system has been the target of vast genetic manipulations. Since the 1970s, it has been known that the outcome of murine infection with S. mansoni varies greatly according to the host's genetic background. Nevertheless, despite the awareness of considerable differences in infection intensity and pathology among mouse strains [5] , most laboratories reported their findings and drew their conclusions based on observations made in only one strain, usually the C57BL/6 (BL/6) strain.
We performed studies on mouse strains of contrasting pathology to examine the underlying immune response to infection and to determine the genetic basis of dissimilar pathology. Prototypic strains are the CBA and C3H mice, which develop severe [5, 6] or extremely severe pathology [7] , and BL/6 mice, in which the pathology is milder (Table 1 ; Fig. 1 ). Severe liver pathology after 7-8 weeks of infection with 80-85 cercariae is typically characterized by large, poorly circumscribed perioval granulomatous lesions composed of a mixture of mono-and polynuclear leukocytes, additional interstitial parenchymal inflammation with variable hepatocyte necrosis, and increasing fibrous scarring. The inflammatory cells include lymphocytes, macrophages, and eosinophils; more recently, neutrophils have also been recognized as important cellular constituents, especially in severe pathology [8] . Unlike in humans, murine neutrophils are more difficult to distinguish from eosinophils by routine histopathological technique and may have been underestimated in the past; assessment by cell marker expression is a more reliable method for proper identification [9] . By comparison, in mice that develop mild pathology, granulomatous and interstitial inflammation in the liver are greatly reduced, and there is little if any hepatocyte necrosis. However, prolonged survival allows for increasing hepatic fibrous scarring during chronicity.
Naturally high-pathology mouse strains, such as the CBA, seem ideal to study the mechanisms conducive to severe disease, yet these strains do not easily lend themselves to gene deletion or transgenesis. On the other hand, mutant low-pathology BL/6 mice are available for a vast array of immunologically relevant molecules. To adapt to this situation, we developed a model of induced severe pathology in BL/6 mice, which consists of subcutaneous immunization with a soluble schistosome egg antigen (SEA) preparation in CFA (SEA/CFA) prior to and once during infection with schistosomes [10] . This treatment results in a proinflammatory shift in immune response with pronounced exacerbation of egg-induced hepatic immunopathology which bears substantial similarity to the natural high-pathology disease (see Table 1 and below).
Our own experience with various mouse strains in terms of immune response and pathology during schistosome infection is summarized in Table 1 and further detailed in subsequent sections of this review. In essence, the mouse model affords a methodical analysis of the host immune response leading to the granulomatous inflammatory process, which, for obvious reasons, cannot be performed in humans.
Parasites and parasite antigens
Schistosomes are parasitic flatworms (platyhelminthes) belonging to the class of trematodes (blood flukes). They are dioecious, that is, there are separate males and females, and they are digeneic, in that they require a permanent and an intermediate host: a vertebrate and a fresh water snail unique to each schistosome species. Upon penetrating the skin of the permanent host, cercariae transform into schistosomula which mature for 3-4 weeks in the lung before arriving at their final intravascular location, where each pair of adults lays hundreds of eggs per day. The molecular cues that allow permissiveness only in certain hosts (permanent or intermediate) or that determine the characteristic final anatomic homing location are not known; as such, for unknown reasons, the mouse is not suitable for patent infection with S. hematobium. The schistosomes typically survive for many years in the permanent host effectively evading immune recognition and expulsion, yet their eggs are highly immunogenic. The capacity of the eggs to engender inflammation was likely selected for during evolution to debilitate tissues and facilitate migration through vascular, mesenchymal, and musculo-epithelial barriers for the purpose of exiting the permanent host and completing the life cycle. Of similar interest are the observations that, for proper development and maturation, schistosomes are dependent on host signals such as those delivered by TGF-β and TNF-α [11, 12] . Owing to an impressive multinational effort, the genome of the schistosomes was fully sequenced and in the case of S. mansoni shown to encode at least 11,809 genes, including those critical for parasite assembly, adaptation, survival, and function [13] . Relevant to the potent immunopathogenicity of the schistosome eggs, 188 of the encoded proteins were found in secretions from live eggs [14] . Among the most abundant of these potentially host-sensitizing egg components that have been the subject of more detailed study are IPSE/alpha 1 (SmEP25) [15, 16] , the omega 1 ribonuclease [17, 18] , the major egg antigen (Ag) Sm-p40 [19] [20] [21] , glutathione S-transferases 26 and 28 kD [22] , phosphoenolpyruvate carboxykinase [23] , thioredoxin [24] , thioredoxin peroxidase [25] , and the secretory glycoprotein kappa 5 (k5) [26] . A salient feature of the schistosome proteins is their rich glycosylation with a complex array of characteristic [39] [40] [41] . Recognition of peptides from processed egg Ags on different Ag presenting cell (APC) types leads to CD4 T cell activation and cytokine production essential for shaping the subsequent inflammatory response. The absence of eggs in the stools of HIV+ patients with schistosomiasis mansoni is an indirect but elegant proof that CD4 T cells are critical in humans for granulomatous inflammation facilitating the transmigration of eggs into the intestinal lumen [42] .
Earlier discoveries revealed that egg Ag-specific CD4 T cell responses result in the production of IL-2 [43] and that parasite egg deposition is a decisive factor in switching an initial Th1-type (IL-2 and IFN-γ) to a Th2-type (IL-4 and IL-5) dominant cytokine environment during schistosome infection [44] . However, appropriate function of the CD80/ 86-CD28, CD40-CD154, and B7RP1-inducible costimulator (ICOS) costimulatory systems is necessary to enable the Cytokine kinetics, shifts and functions during the schistosome infection have been largely inferred from studies performed in the low-pathology BL/6 mouse. However, these conclusions are not necessarily applicable to other mouse strains; in fact, mice with different genetic backgrounds mount strikingly heterogeneous immunopathological reactions to the schistosome infection (see Table 1 and below). Most significantly, in CBA, C3H, and other highpathology mice, overall cytokine production is more robust than in BL/6, and the initial proinflammatory Th1 response does not taper off but persists alongside the rising Th2 response [57] .
Worth recapitulating at this point is the long-known gradual reduction of overall cytokine secretion and consequent granulomatous inflammation in response to tissue-lodging eggs produced after the acute phase of the disease, called "immunomodulation," which to a greater or lesser extent occurs in all mice, regardless of strain. Over time, numerous causes of immunomodulation have been proposed including a role for regulatory T cell (Treg) populations and alternatively activated macrophages (AAM; see below), T cell anergy and IL-2 exhaustion [58, 59], idiotypic networks [60] , and CD4 T cell hyporesponsiveness due to upregulation of grail in response to persistent antigenic stimulation [61] . Of interest is the fact that some regulatory mechanisms underlying immunomodulation may be similar to, or overlap with, those responsible for limiting inflammation in naturally low-pathology strains. They will be discussed in another section below.
The advent of Th17 cells
Until 2005, the heterogeneous outcome of immunopathology and clinical course in a vast number of inflammatory and infectious conditions, including human and experimental schistosomiasis, was considered to be a consequence of the interplay between pro-and anti-inflammatory forces driven largely by Th1 vs. Th2 cells [62] . At this time, however, the field of T cell immunology was revolutionized with the discovery that the immunopathology in several autoimmune diseases was mainly driven by CD4 T cells producing IL-17, rather than by Th1 cells producing IFN-γ [63 -68] . As a consequence, the long-lasting, classical Th1/Th2 paradigm was no longer tenable.
IL-17 is the collective designation of a family of cytokines among which IL-17A, and to a lesser extent IL-17F, are endowed with a powerful proinflammatory function [66] . IL-17A, henceforth called IL-17 and the main focus of the studies described in this review, is a 21-kD homodimeric glycoprotein mainly produced by activated CD4 T cells [66, 69] . These IL-17-producing CD4 T cells were subsequently recognized as a separate lineage of proinflammatory cells unrelated to Th1 or Th2 cells, and were designated Th17 cells after their signature cytokine [70, 71] .
The first notion of the role of Th17 cells in the chronic inflammation associated with experimental autoimmune encephalomyelitis (EAE) came from experiments showing that mice lacking IL-12p40 and IL-23p19 failed to develop EAE, whereas in those lacking IL-12p35 the disease was similar to that observed in wild-type controls. These results demonstrated that the immunopathology was dependent on IL-23, a member of the IL-12 superfamily of heterodimeric cytokines which is composed of subunits IL-12p40 and IL23p19 and is involved in the generation of Th17 cells, rather than on IL-12 itself, which is composed of subunits IL12p40 and IL-12p35 and is necessary for the development of Th1 cells [72] . A pathogenic role of Th17 cells, similar to that in EAE, was also demonstrated in other human and experimental autoimmune disorders including collageninduced arthritis (CIA) [73, 74] , myocarditis [75] , and colitis [76] . However, Th17 cells were also shown to be involved in immunity to some pathogens including the bacteria Klebsiella pneumoniae [77, 78] and Citrobacter rodentium [79] , as well as the fungus Candida albicans [80, 81] . Ironically, Th17 cells were first discovered for their harmful role in T cell-mediated autoimmunity, and only later were they shown to be effective in the control of certain extracellular microbial infections.
Of great interest were reports from a number of laboratories describing the requirement for several cytokines in the generation of Th17 cells, suggesting that there is considerably greater complexity in, and controversy about, the development of cells of this lineage than is the case for Th1 or Th2 cells. Such cytokines, derived from dendritic cells (DC) and other APC, which include IL-1β and IL-21 in addition to IL-23, IL-6, and TGF-β, were shown to play overlapping and complementary roles in the differentiation and expansion of Th17 cells [82] [83] [84] [85] . This process requires the expression of the corresponding receptors for these cytokines on naïve target T cells and activation of signaling pathways including the signal transducer and activator of transcription-3 (STAT3) and the master lineage-specific transcription factor retinoic acid-related orphan receptor (ROR)-γt [86] . Th17 cells exert their potent proinflammatory function by secreting IL-17A and IL-17F, as well as IL-22, IL-21, granulocytemacrophage and granulocyte colony-stimulating factors, which stimulate the production of the chemokines CXCL1, CXCL2 (and CXCL8 in humans) by fibroblasts, lymphoid, endothelial and epithelial cells expressing the corresponding receptors such as the IL-17 receptor (IL-17RA), ultimately resulting in neutrophil-rich inflammatory cell infiltrates.
The role of Th17 cells in schistosomiasis
Since the immunobiology of the schistosome infection has so much in common with T cell-mediated autoimmune diseases, we began exploring the role of IL-12 superfamily cytokines using subunit-deficient BL/6 mice, which were immunized with SEA/CFA to boost their otherwise natural low pathology [10] . In BL/6 mice, such an immunization causes marked exacerbation of egg-induced hepatic inflammation together with a significant increase in both IFN-γ and IL-17 production by SEA-stimulated T cells (Table 1) . Remarkably, the immunization completely failed to elicit pathology exacerbation and IL-17 production in IL-12p40 −/− (IL-12 and IL-23 deficient) mice, while in IL-12p35−/− (IL-12 deficient and IL-23 sufficient) mice IL-17 production and immunopathology were similar to that seen in wild-type controls [87] . These findings suggested that IL-17 driven by IL-23, but not IFN-γ, was at the root of the severe disease, a fact further supported by the inhibition of pathology following treatment with anti-IL-17 Ab [87] . A close direct look at IL-23, afforded by mice deficient in IL-23p19 (IL-23p19−/ −), revealed a significantly impaired immunopathology together with a marked reduction in IL-17 in the hepatic granulomas but not in the mesenteric lymph nodes [8] . In the IL-23p19−/− mice, there were also low levels of IFN-γ regulated by high IL-10, and there was evidence that macrophages in the granulomas were in a state of alternative activation (see later). Taken together, these results not only demonstrated that IL-17 is critically involved in the immunopathology but also that IL-23 is not the only requirement for IL-17 production. Interestingly, a third cytokine of the IL-12 superfamily, IL-27, did not exert significant influence on the granulomatous inflammation [88] .
Severe egg-induced immunopathology, whether naturally occurring in several mouse strains (Table 1 ) or in this case induced by immunization of BL/6 mice with SEA/CFA, is invariably linked to high IFN-γ and IL-17 levels produced by SEA-stimulated mesenteric lymph node cells (MLNC). However, these cytokines play entirely disparate roles in granuloma pathogenesis as demonstrated in BL/6 mice deficient in the T-box transcription factor T-bet, which is required for IFN-γ production and Th1 cell development and function [89] . Schistosome-infected T-bet−/− mice unexpectedly displayed significantly more severe neutrophilrich hepatic granulomatous inflammation and greater T cell activation with increased production of IL-17, IL-21, IL-22, and the neutrophil chemokines CXCL1 and CXCL2 together with lower levels of IL-4, IL-5, and IL-10 and a decrease in markers associated with AAM and Treg cells. Mice deficient in IFN-γ (IFN-γ−/−) similarly exhibited increased immunopathology with elevated IL-17 levels, whereas in mice lacking IL-17 (IL-17−/−) the pathology was markedly reduced despite IFN-γ levels that were even higher than in wild-type controls [90] . Interestingly, novel mice doubledeficient in IL-17 and IFN-γ (IL-17/IFN-γ−/−) displayed the smallest granulomas, similar to those seen in unimmunized wild-type BL/6 mice, along with higher levels of IL-5, IL-10, and the AAM marker resistin-like molecule α (Relmα; also known as FIZZ1), as well as reduced expression of IL23p19, IL-1β, and CXCL1. Taken together, these findings demonstrate (a) that Th17 cells play a critical role in the development of severe egg-induced inflammation, which is normally regulated by Th1 cells, (b) that in the absence of IL-17, Th1 cells can mediate limited pathology, (c) that IL-17 and IFN-γ are cross-regulatory during schistosome infection, and (d) that in the absence of both IL-17 and IFN-γ, default background low pathology is mediated by Th2 cells with a likely contribution from innate immune mechanisms.
To more carefully dissect interactions between immune cells and the parasite, we examined cytokine levels in an in vitro co-culture system involving bone marrow-derived DC stimulated with live schistosome eggs in the presence of naïve syngeneic CD4 T cells nonspecifically stimulated with anti-CD3/CD28-coated beads [91] . In CBA-derived cocultures, T cells produced high levels of IL-17. In contrast, BL/6 T cells while capable of producing IL-17 in response to a combination of exogenous IL-6, TGF-β and IL-23, failed to do so in response to DC plus eggs, indicating that enhanced IL-17 production in CBA co-cultures is due to stimulation with the schistosome eggs. The CBA cells also expressed significantly higher levels of transcripts for IL12p40, IL-23p19, IL-1β, IL-6, CXCL1, and CXCL2, whereas IL-4, IL-10, and Foxp3 were higher in BL/6. Notably, blocking Ab specific for IL-12p40 and IL-23, but surprisingly not for IL-6 and IL-21, significantly inhibited IL-17 production in the CBA cultures [91] . In related experiments, IL-17 production by novel Sm-p40-specific Tg T cells (Box 1) in response to stimulation with DC plus eggs, was found to be sequentially dependent on IL-23 and IL-1β, but again not on IL-6. Consequently, there was significant inhibition of immunopathology and IL-17 production in schistosome-infected IL-12p40−/− CBA mice and in mice treated with IL-1R antagonist [31]. These results indicated that both the naïve and Tg T cells were dependent on IL-23 and IL-1β for differentiation into Th17 cells, while IL-6 was dispensable. This pattern differs with studies demonstrating a requirement for IL-6 and TGF-β [79, 81, 92, 93] . However, it is well established that the cytokine requirements for Th17 cell differentiation and pathogenicity, including IL-6, TGF-β, IL-23, IL-1β, and IL-21, vary significantly depending on the system examined, the nature of the T cells, and the species (human vs. mouse) [94] [95] [96] . For example, IL-6 and TGF-β were shown to be necessary to drive Th17 differentiation in sorted CD4+ CD44 lo CD62L hi naïve T cells [97] , whereas our studies were performed with unselected purified naïve CD4 T cells obtained from normal mice, which were exposed to IL-6 in vivo and are more representative of cells naturally confronting a new Ag or pathogen in vivo [31] .
An important notion from the above findings is the remarkable heterogeneity of the host immune response to schistosome infection involving different APC, T cell subsets and cytokines, resulting in contrasting levels of immunopathology (Fig. 2) . Such differences are well documented in other parasitic diseases, notably leishmaniasis [98, 99] , but have not received equal attention in schistosomiasis. The disparity in strain-specific responses to schistosome Ags begs the investigation of innate immune recognition mechanisms that may be responsible for stimulating different cytokine secretion programs and inducing different T cell subsets. Our initial gene profiling of bone marrow-derived DC populations from naïve CBA and BL/6 mice revealed profound differences in innate pattern recognition receptor expression between these strains. Of particular interest were the C-type lectin receptors, specifically the murine homologues of human DC-specific ICAM-3-grabbing nonintegrin (DC-SIGN, CD209) which was shown to bind schistosome-derived glycans [100, 101] . Current efforts focus on elucidating potential innate receptors that recognize egg components and precipitate signaling cascades resulting in proinflammatory cytokine production and severe disease.
Recent data from other groups have significantly broadened the scope of Th17 cell involvement in schistosomiasis. In BL/6 mice infected with S. japonicum, the natural hepatic egginduced granulomatous inflammation is considerably more pronounced than in S. mansoni infection and correlates with increased expression of IL-17, IL-6, TGF-β, IL-23p19, IL-1β, TNF-α, CXCL1, and CXCL2 [102] . Moreover, neutralization of IL-17 in vivo resulted in significant amelioration of pathology, diminished lesional neutrophil recruitment, and a reduction in proinflammatory cytokines [102] . Most significantly, flow cytometry analysis has shown that IL-17 and ROR-γt expression by CD4+ T cells, as well as IL-17/IL-10 and ROR-γt/Foxp3 ratios, are significantly increased in peripheral blood mononuclear cells (PBMC) from S. hematobium-infected Senegalese patients with bladder pathology in comparison with uninfected individuals or infected patients without detectable bladder pathology. Interestingly, when comparing S. mansoni-infected CBA and BL/6 mice, the characteristic disparity in the magnitude of immunopathology directly correlates with flow cytometric analysis of IL-17 expression in CD4 T cells isolated from PBMC, spleen, and hepatic granuloma cells, suggesting that the PBMC profile seen in humans is representative of that prevailing in lymphoid and target organs [103] .
Regulation of the immune response and immunopathology in schistosomiasis
Studies aimed at elucidating the complex immunopathogenic host response in schistosomiasis run parallel to, and are intimately interwoven with, those examining the regulatory mechanisms that prevent or oppose the development of excessive disease. Over the past three to four decades, many immunoregulatory pathways put forward in general immunology have been studied in the context of schistosomiasis. However, since these pathways were described before the discovery of Th17 cells, their direct impact on this T cell subset has not been formally documented and can only be inferred.
Treg cells and AAM are cell types that can exert a powerful regulatory function in numerous biological systems [104] [105] [106] [107] [108] . Together with Th2 cells, Treg cells and AAM represent key players in the regulation of excessive schistosome-induced pathology [109] [110] [111] , and it is likely that these cells make use of some common mechanisms to dampen inflammation in the chronic phase of infection (immunomodulation) as well as in mouse strains that naturally develop mild immunopathology. In particular, IL-4-dependent AAM are indispensable for the development of a Th2 response and for averting severe disease and death [49] . We have observed the expression of AAM markers, including the chitinase-related molecule Ym1, Relmα, and arginase, and the Treg lineage-specific transcription factor Foxp3 to inversely correlate with hepatic egg-induced immunopathology and IL-17 levels [112] . Similarly, these cell markers were decreased in infected SEA/CFA immunized Tbet−/− mice displaying exacerbated immunopathology and high levels of IL-17 [89] . Whether in conjunction with or independent of Treg cells and AAM, IL-10 represents a powerful regulatory force during schistosome infection as demonstrated by its capacity to curtail immunopathology when administered in vivo, as well as by the marked exacerbation of disease that results from its absence [54-56]. Interestingly, co-production of IL-10 by Th17 cells induced with IL-6 and TGF-β completely abrogated their pathogenicity in a model of central nervous system inflammation [113] . Formerly considered a Th2 cytokine, IL-10 is now known to be produced by all CD4 T cell subsets and by other lymphoid and non-lymphoid cells [114, 115] . One caveat is that the inhibitory role of IL-10 in schistosomiasis has been assessed and well documented in the BL/6 strain and that in CBA mice its ample presence does not necessarily result in reduced pathology. It is possible that genetic polymorphisms might affect IL-10 or IL-10R structure and signaling, and thus appropriate function; however, the failure to regulate high pathology in some strains likely extends beyond the biology of IL-10.
Of increasing importance among the regulatory mechanisms of the immune response are coinhibitory systems mediating inhibition of T cell activation and proinflammatory cytokine production. Programmed death 1 (PD-1), largely expressed on T cells, and its ligands PD-L1, widely expressed on lymphoid and non-lymphoid cells, and PD-L2, expressed mainly on DC and macrophages, represent one such coinhibitory system that has been demonstrated to regulate autoimmune and pathogeninduced inflammation [116] . In schistosomiasis, increased PD-L2 expression on CD11c+ DC was associated with decreased morbidity [117] . Additional studies are necessary to more thoroughly explore the role of the PD-1/PD-L and other coinhibitory systems on the outcome and possible control of immunopathology in schistosomiasis. Fig. 2 Development of CD4 T cell subsets in severe and mild forms of murine schistosomiasis. In the case of severe immunopathology (top), egg Ag binding to pattern recognition receptors (PRR) on APC, such as dendritic cells (DC) and macrophages, followed by internalization, processing, and presentation in context with MHC class II and costimulatory molecules, results in the production of cytokines that activate Ag-specific CD4 Th17, Th1, and Th2 T cells. The activated T cells produce lineage-specific cytokines that create an overall proinflammatory environment leading to vigorous leukocyte recruitment in response to tissue-trapped eggs and thus severe immunopathology. In this setting, macrophages undergo classical activation (CAM). In the case of mild immunopathology (bottom), possibly weaker egg Ag binding to fewer or even different PRRs on APC leads to Ag presentation in the context of coinhibitory rather than costimulatory molecules and results in the production of cytokines that induce and activate Ag-specific Th2 and T regulatory (Treg) cells. These T cells produce lineage-specific cytokines that create an overall antiinflammatory environment resulting in diminished leukocyte recruitment and tempered immunopathology. Under these conditions alternatively activated macrophages (AAM) predominate. Most examined mouse strains develop severe immunopathology with Th17 as well as Th1 and Th2 responses to varying degrees (top); a plain Th2-polarized response (bottom) is an exception that is observed in low-pathology strains such as BL/6. TGF-β transforming growth factor-β, CSFs colony stimulating factors, TNF-α tumor necrosis factor-α
The low prevalence of autoimmune diseases in populations inhabiting tropical regions of the world has been attributed to the coexistence of helminthic infections and has led to the formulation of the hygiene hypothesis [118] [119] [120] . Indeed, down-modulation of disease severity by helminth coinfection in various models of experimental autoimmunity has lent abundant credence to this hypothesis [121] [122] [123] [124] [125] . Given the many mechanistic similarities between the immunopathology of T cell-mediated autoimmune diseases and schistosomiasis, we assessed the impact of a coinfection with the murine gastrointestinal parasitic nematode helminth Heligmosomoides polygyrus on the severe schistosome-induced pathology characteristic of CBA mice and SEA/CFA-immunized BL/6 mice. In both instances, there was significantly reduced immunopathology in the coinfected mice, which was accompanied by decreased MLNC and granuloma cell production of IL-17, IFN-γ, and TNF-α and increased production of IL-4, IL-5, IL-10, and TGF-β [112] . How H. polygyrus manages to switch schistosome-infected mice from a Th17/Th1-polarized response with severe pathology to a predominantly Th2 response with mild pathology still remains to be fully understood, but may depend on its ability to stimulate Foxp3 expression and regulatory capabilities in naïve CD4 T cells by way of excretory/secretory products [126] or to induce AAM differentiation [49] . In support of the latter possibility, expression of the AAM markers Ym1 and Relmα was significantly increased in the livers of H. polygyrus and S. mansoni coinfected mice compared with mice infected with S. mansoni alone [112] . Yet another significant way that intestinal nematodes such as H. polygyrus could influence the immunopathology of schistosomiasis is by virtue of their ability to alter the composition of the gut microbiota [127] . Recent studies have demonstrated a connection between specific microbial communities and the development of immune responses and immunopathology [128] [129] [130] both locally in the intestine and systemically, including models of Th17-dependent autoimmune disease such as EAE [131, 132] . Further evidence linking microbes with the outcome of T cell subset development and pathology in schistosomiasis comes from two observations. The first is the previously mentioned stimulation of Th17 cell development and exacerbation of egg-induced inflammation in infected BL/6 mice immunized with an emulsion of SEA in CFA (which contains killed mycobacteria) and the second is the ability of BL/6 DC co-pulsed with SEA and heatkilled Proprionibacterium acnes to switch induction of SEA-specific T cell cytokine production from a Th2 (IL-5/ IL-13) to a Th17 (IL-17) phenotype [133] . In both cases engagement of, and subsequent signaling by, innate pattern recognition receptors by microbial products likely accounts for the altered responses. Certainly, in both instances the results were obtained from experimental setups but the findings likely reflect real-life situations such as the perforation of the intestine by schistosome eggs, potentially facilitating the entry of bacteria into the circulation. The important point to be made is that gut microbial communities, which are determined by a multiplicity of factors including habitat, diet, host genetic background and coexistence of parasitic nematodes, can significantly influence pathogenic immune responses and thus can up-or downregulate the severity of the schistosome infection both in experimental systems as well as naturally in humans.
Genetic control of murine schistosomiasis
The marked heterogeneity of immune response and immunopathology in humans and among inbred mouse strains following infection with schistosomes has prompted considerable efforts to map the genetic intervals responsible for governing such disparate traits. Despite formidable obstacles afforded by genetic polymorphisms of humans and schistosomes alike, by uneven parasitic loads, and by intercurrent infections and/or other medical and social factors, quantitative trait loci (QTL) analysis succeeded in identifying genomic intervals associated with disease susceptibility or pathology. Work by Dessein and colleagues has identified two major loci associated with human disease: the first, designated SM1, was identified in a Brazilian population and linked to intensity of infection, while the second, designated SM2, was identified in a Sudanese population and linked to severe hepatic fibrosis [134, 135] . These loci were found to be independent of one another, supporting earlier evidence that infection levels do not necessarily correspond to disease severity. Interestingly, these data suggest that anti-infection and antidisease immunity are under distinct major gene control, which may have a significant clinical impact in the future, particularly as the risk of schistosome resistance to praziquantel increases.
Notwithstanding this early work and subsequent major advances in genome sequencing and analysis, it remains particularly difficult to identify polymorphic genes associated with complex diseases in humans. Fortunately, in S. mansoni infection, the murine disease closely mimics that in the human, making it an ideal model for genetic study. We used multiple crosses of genetically diverse mice to identify relevant loci governing differences in immune response and immunopathology (Fig. 3) . Of great interest was the observation that in all the examined crosses between high and lowpathology strains, low pathology was dominant in the F1 progenies, whereas in the F2 generations it predictably ranged from very low to very high.
An initial F2 analysis between high-pathology CBA and low-pathology BL/6 mice disclosed a linkage between granuloma size and IFN-γ levels in supernatants from SEAstimulated MLNC and identified several genetic intervals linked to IFN-γ production, including two highly suggestive loci on chromosomes 1 and 5 [136] . These loci were shown to have a significant epistatic interaction and contain several candidate genes, including Adprt1 and TLR5. In addition, a single locus on chromosome 13 had a highly suggestive linkage to granuloma formation; this locus contains several genes of the serpin family of protease inhibitors and has been implicated previously in wound healing and neutrophil infiltration.
To further understand the genetic complexities of the schistosome infection, we performed a second, more comprehensive analysis using a cross between a different strain of mice with particularly severe pathology, SJL, and the low-pathology BL/6 mice (Table 1) [137] . This study provided us with the first opportunity to assess genetic control of the IL-17 response during murine schistosome infection, which had been recently identified as a close correlate and more reliable marker of high pathology [87] . In an (SJL x BL/6) F2 cohort, there was a highly significant correlation between granuloma size and IL-17, IFN-γ, and TNF-α but not with IL-4, IL-5, and IL-10. QTL analysis identified two loci that were highly significantly linked to granulomatous inflammation, located on chromosomes 4 and 17. The locus on chromosome 4 contains a number of overlapping QTL for several autoimmune diseases with similar pathogenic mechanisms to schistosomiasis, including EAE and systemic lupus erythematosus (SLE) [138, 139] , with several candidate genes implicated in immune functions including the signaling proteins, lck and map3k6, as well as IL-22ra1. The locus on chromosome 17 has also been linked with EAE and SLE and contains additional overlapping QTL with resistance to malaria (Char3) and leishmaniasis (Lmr1) [140, 141] . The most immunologically relevant candidate genes within this interval are Tnfa and Notch3, both of which are known to play roles in autoimmune and inflammatory diseases, as well as T cell development in the case of Notch [142] . In addition to granuloma formation, we also identified several loci associated with IL-17 production, among which D4Mit211 exhibited a highly significant linkage, whereas in 4 additional loci the linkage was suggestive (Fig. 3) . Interestingly, the loci on chromosomes 3 and 9 contain the genes encoding the Th17-specific transcription factors ROR-γt and ROR-α, respectively. Potential candidate genes residing within this locus include the runx-like transcription factor Runx1tl and Map3k7 or TAK1.
Since QTLs governing schistosome-induced murine (and human) immunopathology and/or cytokine expression could be directly or indirectly influenced by genes within the MHC, as exemplified by the described locus on chromosome 17 in the SJL×BL/6 cross [137] , we sought to investigate genetic intervals controlling phenotypic differences in (Table 1) . Enhanced pathology seen in parental BL/10 mice, as well as in a fraction of mice from a (BL/10×BL/6) F2 cohort, is associated with an increase in IL-17 and IFN-γ produced by SEA-stimulated MLNC. Most interestingly, recent work involving a series of congenic mice containing defined BL/10 segments on a BL/6 background, revealed enhanced pathology to be associated with intervals in chromosomes 4 and 13, in locations similar to those previously mapped, respectively, in the above described BL/6×SJL and BL/6× CBA crosses. Congenic mice with enhanced pathology also expressed higher levels of IL-17, IL-23 and IL-1β together with lower levels of IL-5 and the AAM markers Relmα and Ym1 (P. M. Smith, T. Sproule, D. Roopenian, and M. J. Stadecker, unpublished observation).
The complex genetics of the schistosome infection has made it difficult to discover true candidate genes, despite the number of QTL identified to date. We reasoned this could be due, at least in part, to the limited genetic diversity among classical inbred mouse strains. To overcome this limitation, we analyzed the schistosome infection in wild-derived mouse strains, which diverged from a common ancestor with classically inbred strains over one million years ago and possess a more diverse gene pool, making them more likely to reveal novel mechanisms of immune regulation [143] [144] [145] . Interestingly, schistosome-infected wild-derived inbred mice of the MOLF/ei strain develop severe natural perioval granulomatous inflammation together with high levels of IL-17 [146] ( Table 1) . Using congenic mice on a BL/6 background with a MOLF/ei locus on chromosome 6, we discovered that the high pathology developed by these mice was based on a single gene, IL-1-receptor associated kinase-like 2 (Irak2), which increases T cell-intrinsic sensitivity to IL-1-β-induced activation of the Th17-lineage-specific transcription factors ROR-γt and basic leucine zipper transcription factor, ATF like (BATF), thus enhancing Th17 cell differentiation.
Taken together, we have used different genetic crosses as well as classical and non-classical mouse strains to better understand the complex genetics underlying murine schistosomiasis, and identified a number of loci throughout the genome that are linked to both cytokine production and immunopathology (Fig. 3) . Some loci were identified repeatedly and had significant epistatic interactions with one or more additional loci, whereas others appear to function independently and were identified in only one cross, which is indicative of the multiplicity of genes involved in the host immunopathological response to infection with schistosomes. In future work it will be challenging to refine these identified QTL and to discover the underlying genes.
Conclusions
The granulomatous inflammatory pathology in schistosomiasis centers around parasite eggs and is mediated and orchestrated by CD4 T cells specific for egg Ags. Until recently, the markedly dissimilar outcome of disease severity, found both in humans and among mouse strains, was largely attributed to the interplay of pro-vs. anti-inflammatory forces carried out by Th1 vs. Th2 cells. However, the discovery of Th17 cells and their central pathogenic role in T cell-mediated autoimmune diseases prompted a dramatic paradigm shift regarding the role of Th cell subsets in a number of immune and inflammatory responses. Before their discovery, many functions of Th17 cells were attributed to Th1 cells, with which they frequently overlap, but new evidence suggests that in many instances Th1 cells regulate Th17 cells since pathogenic Th17 cell responses are magnified in their absence. Our investigation of Th17 cells indeed uncovered this subset to be intimately tied to the development of exacerbated egg-induced inflammation in schistosomiasis. Studies in infected gene knock-out mice and in an in vitro system using either normal T cells or Tg T cells bearing a transgenic TCR specific for the major Sm-p40 egg Ag, demonstrated Th17 cell differentiation to be dependent on IL-23 and IL-1β produced by APC following stimulation with egg-derived products (Fig. 2) .
Historically schistosome infections have been considered to result in Th2-dominated cytokine polarization. However, in the murine infection, a plain Th2 polarization seems to be the exception applicable only to low-pathology strains such as the BL/6. Rather, most examined strains, including members of the subspecies of wild-derived mice, develop considerably more severe pathology associated with elevated Th17, Th1, as well as Th2 cell responses (Table 1 ). Genetic analysis disclosed that severe pathology and high IL-17 levels are controlled by several independent or overlapping loci. However, the loci vary among the different crosses between high and low-pathology strains, which is indicative of the complex, multigenic nature of these traits in each case (Fig. 3) .
Aside from the cognate interaction with egg Ag, a number of factors shape the ensuing schistosome-specific T cell response. Central among these are the innate receptor repertoire and cytokine profile of the APC that activate T cells, as well as the costimulatory and coinhibitory signals affecting APC-T cell interactions. Once established, pathogenic T cell responses must be subjected to regulatory forces, such as those delivered by Treg cells and AAM. Of note also are the effects of coinfection with intestinal helminths in mitigating schistosome egg-induced immunopathology, which in humans may explain the net prevalence of mild clinical disease in areas of coendemicity. Our current research is directed at further elucidating the nature and impact of innate receptors affording the initial recognition of schistosome-derived ligands as well as the mechanisms involved in mediating regulation. In practical terms, these studies are aimed at devising strategies to control damaging inflammation similar to those presently used to manage other immune-mediated diseases. 
